Smith+Nephew Welcomes Encouraging Start to 2022
The company grew in the low single digits for the first quarter and expects the orthopedic market's recovery to accelerate throughout 2022 May 03, 2022
Stryker’s Early 2022 Growth Constrained by Supply Pressures
The company grew in the mid-single digits for 1Q22 as procedure recovery fueled growth. However, supply chain pressures offset some gains. Apr 29, 2022
DePuy Synthes’ ASC Focus Spurs Knee and Hip Growth
The company grew in the low single digits for 1Q22, driven in part by knee replacement and hip replacement gains in the ASC setting. Apr 20, 2022
Orthopedic Market Unlikely to Find Reprieve in 2022
Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022. Mar 23, 2022
R&D Spend Just One Problem for Lagging Portfolios
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies. Mar 21, 2022
ZimVie CEO on Driving Stability and Innovation in Spine
We spoke to ZimVie CEO Vafa Jamali about the new opportunities and finding the right areas of the spine market to drive innovation. Mar 18, 2022
Bioventus Focused on Integrating Recent Acquisitions
The company grew over +28% in 2021, driven in part by synergies from recently acquired Bioness and Misonix. Mar 14, 2022
Paragon 28 Sets Out to Modernize Foot and Ankle Surgery
The company grew almost 33% in 2021 and expects its focus on medical education and enabling technology will spur further growth. Mar 11, 2022
Anika Loses Line of Sight on Multi-Year Growth Targets
The company grew in the low-teens for 2021 but the ongoing effects of the pandemic caused Anika to adjust its growth timeline. Mar 10, 2022
Medartis Aims for Leadership Position in Extremities
The company grew +25% in 2022 and took its U.S. business to the next level with the acquisition of Nextremity Solutions. Mar 09, 2022
